ACM
CGON icon

ADAR1 Capital Management’s CG Oncology CGON Stock Holding History

ADAR1 Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.6M Sell
185,699
-72,440
-28% -$4.1M 0.76% 34
2025
Q4 		$10.7M Buy
258,139
+9,222
+4% +$382K 0.8% 33
2025
Q3 		$10M Sell
248,917
-274,299
-52% -$7.97M 0.99% 25
2025
Q2 		$13.6M Buy
523,216
+222,082
+74% +$5.35M 2.21% 11
2025
Q1 		$7.37M Buy
301,134
+85,384
+40% +$2.4M 1.42% 17
2024
Q4 		$6.19M Buy
215,750
+72,646
+51% +$2.49M 1.28% 17
2024
Q3 		$5.4M Buy
143,104
+130,254
+1,014% +$4.57M 0.91% 27
2024
Q2 		$406K Buy
12,850
+10,800
+527% +$374K 0.08% 109
2024
Q1 		$90K Buy
+2,050
New +$83.7K 0.02% 156

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM